🔬 Can causal human biology change the odds of drug discovery?
BMS Chief Research Officer @rplenge joins @rahulc to explore target diversity, immune reset, AI in R&D, blended innovation & the future of transformative medicines.
🎧 - on.soundcloud.com/5z8XpzDC0q…
#Biotech2050 #Biotech
🧬 From a fringe scientific bet to pioneering targeted protein degradation.@KymeraTx CEO @NelloMainolfi joins @rahulc on #Biotech2050 to discuss drug discovery, immunology, disciplined growth & building a culture that can do what’s never been done. 🎧 - on.soundcloud.com/ksNbuIbEJt…
AI won't replace scientists - it will redefine drug discovery
@rahulc talks w/ @nick_myerberg, Partner & Head of AI @braidwell, on AI-native biotech, proprietary data, autonomous labs & why the next decade could transform how medicines are discovered
🎧 - on.soundcloud.com/cUxDlhSnqD…
From civil engineer to biotech CEO.
@rahulc speaks with Robert Jacks, CEO of @Sparrow_Pharma, on building sustainable biotech companies, precision medicine, cortisol biology, & the future of treating difficult-to-control diabetes. 🎧 - on.soundcloud.com/hc4cVoW7qs…
#Biotech2050
What does patient-centricity look like when embedded in C-suite?
@ardelyx CEO Mike Raab & Chief Patient Officer Laura Williams join @rahulc to share lessons on leadership, perseverance, patient advocacy, & navigating the FDA journey. 🧬❤️ 🎧 - on.soundcloud.com/hIb2q3Oa13… #Biotech2050
How do you go from pharmacist to leading a billion-dollar biotech? Catherine Owen Adams, CEO of @AcadiaPharma, joins @rahulc on #Biotech2050 to discuss neuro & rare disease innovation, commercialization, AI, & first-time CEO lessons. 🧠 🎙️- on.soundcloud.com/nXJ0ArsZaZ…
This episode is sponsored by @Quartzy.
Barry Quart, CEO of Connect Biopharma, joins @aloktayi on #Biotech2050 to discuss IL-4 biology, ER-based innovation, biotech funding realities & cross-border strategy in a complex global market. 🧬📊🌍 #Biotech #Asthma #COPD #Biologics
This episode is sponsored by @Quartzy.
Sheila Gujrathi, MD joins @rahulc on #Biotech2050 to discuss leadership, venture building, & lessons from her book The Mirror Effect on confidence, leadership & navigating power in biotech
🎧 on.soundcloud.com/RPVtOCG58w…
#TheMirrorEffect #biotech
Recorded at JPM 2026: @aloktayi speaks with Lundbeck EVP, R&D Johan Luthman on rebuilding neuroscience pipelines, Alzheimer’s breakthroughs, rare disease strategy & AI-driven R&D. A masterclass in disciplined drug development. 🧠🚀 #Biotech2050
🎧 - on.soundcloud.com/k5YRAf4SH2…
How do you build a $2B biotech without losing sight of the patient?
@LEOHealthySkin CEO Christophe Bourdon joins @aloktayi on #Biotech2050 to discuss dermatology innovation, rare disease execution, AI-driven scouting & why “me-too” drugs aren’t enough 🎧 - on.soundcloud.com/SyG3o0jHQ2…
This episode is sponsored by @Quartzy.
How do you turn Phase 3 wins into durable biotech value?
@Roivant CEO @gline joins @rahulc on #Biotech2050 to discuss clinical breakthroughs, capital discipline & building biotech that lasts. 📊 🧬
🎧 Listen: on.soundcloud.com/jPqcFjwmNu…
Sponsored by @Quartzy
Cancer doesn’t fight fair—so @DiakonosOnc rewrote the immune playbook
Jay Hartenbach joins @aloktayi to reveal how dual-loaded dendritic cells trigger viral level immune attacks in GBM, pancreatic cancer & melanoma 🧬
🎧 on.soundcloud.com/i0qsGLeTFa…
#Biotech2050
The episode is sponsored by @Quartzy.
🔬 “What if we’ve only mapped a fraction of human proteins?”
@rahulc interviews John Lepore, CEO of @ProFoundTx, on AI, risk-taking, & the next frontier of first-in-class medicines powered by the expanded proteome.
🎧 on.soundcloud.com/xmG2cQ8FBp…
Biotech needs a systems reboot. 🧬
Host @aloktayi talks with @jrkelly, CEO & Co-Founder of @Ginkgo, about automation, AI-ready data, fixing drug dev economics, & why now is still a great time to start a biotech.
Listen: on.soundcloud.com/WkQAEm1j8u…
#Biotech2050 #AIinBiotech
🧬 New #Biotech2050 episode with @AbbasRKazimi, CEO of @NimbusTx.
He joins @aloktayi to talk founder mentality, “love the portfolio” decision-making, embracing attrition, and leading calmly through FDA shifts, geopolitics & funding uncertainty.
Listen 👉 on.soundcloud.com/v3pYaVbEwe…
💸 Interest rates 🤖 AI 🧠 Human insight
All shaping the future of biotech.
🎙️ @JTananbaum, Founder & CEO of @foresitecapital, joins @rahulc on #Biotech2050 to unpack venture cycles, AI’s rise in drug discovery, & next wave of innovation.
🎧 Listen now →on.soundcloud.com/QtQ8QCZskz…
Biotech’s next wave is polymer-powered. 💥 @rahulc talks w/ Geoffrey Duyk, CEO of Grove Biopharma, on tackling “intractable” targets, fixing R&D inefficiency, & rebuilding trust in science. 🎧 Listen and learn more: on.soundcloud.com/XSF8A7QqSY…
#Biotech2050 #DrugDiscovery #Innovation
Thrilled to share that our very own host, @rahulc, joins the panel at @SyneosHealth’s Heart of Health during #FierceBiotechWeek 🧬💬
Powerful insights on innovation, empathy & the future of biotech.
🔗 Check it out: linkedin.com/posts/syneoshea…
#HeartOfHealth #Biotech2050
#Biotech2050 Episode sponsored by @MeetClora 🌟 #Biotech thrives on co-creation. @rahulc talks w/ @PaulBiondi9 (@FlagshipPioneer) & Uli Stilz (@novonordisk) on trust, innovation & partnerships driving breakthroughs in obesity & diabetes. 🎧 on.soundcloud.com/egIyMU7coT…
#DrugDiscovery
A must-listen🎙️ @rahulc chats w/ @KevinCaldweII, CEO of @OssiumHealth, on building a vertically integrated cell therapy platform, scaling immune health, & leading with bold vision. From astrophysics to biotech innovation 🚀
Listen: on.soundcloud.com/JDbsHEUh1D…
#Biotech2050 #StemCells